5AM Partners VII, LLC (DIEKMAN JOHN D, PARMAR KUSH) sold $65K of SKYE (indirect holdings)
5AM Partners VII, LLC sold 33,892 indirectly-held shares of Skye Bioscience, Inc. (SKYE) at $1.91 across 2 trades on 2026-09-16. Filed jointly with 5AM Ventures VII, L.P. (10% owner), 5AM Partners II, LLC (10% owner), 5AM Ventures II LP (10% owner), 5AM CO-INVESTORS II LP (10% owner), DIEKMAN JOHN D (10% owner), PARMAR KUSH (10% owner) and ROCKLAGE SCOTT M (10% owner).
How this was made
The 30-second read
Why it matters
Provides fresh, primary‑source data on insider activity; limited trading relevance.
Market read
Small insider sell; unlikely to affect broader market.
What to watch
Potential upcoming financing or dilution events not disclosed.
Background
Form 4 filing by a 10% owner of Skye Bioscience detailing an open‑market sale.
Ticker impact
5AM Partners VII sold 33,892 shares of Skye Bioscience for $64,734, reducing its stake to 5,616 shares.
minimal impact, possible slight downward pressure
The transaction size (~$65k) is small relative to market cap; insider is a 10% owner but sale is modest and disclosed via Form 4, the first report.
Market effects
Limited effect on biotech sector; typical insider sell signals no major upcoming news.
None
None
Counterpoint
The sale could be a routine portfolio rebalancing, not a negative signal.
Key entities
- CompanySkye Bioscience, Inc.
Biotech firm listed on NASDAQ under SKYE.
- Investor5AM Partners VII, LLC
Insider holder selling shares.